Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 03:09PM ET
2.34
Dollar change
-0.39
Percentage change
-14.29
%
Index- P/E- EPS (ttm)-9.20 Insider Own17.25% Shs Outstand8.58M Perf Week10.38%
Market Cap18.84M Forward P/E- EPS next Y-3.95 Insider Trans0.00% Shs Float6.66M Perf Month-21.48%
Income-66.27M PEG- EPS next Q-1.67 Inst Own14.12% Short Float5.54% Perf Quarter-33.78%
Sales2.45M P/S7.69 EPS this Y36.19% Inst Trans103.52% Short Ratio4.92 Perf Half Y-42.54%
Book/sh-6.62 P/B- EPS next Y32.47% ROA-147.36% Short Interest0.37M Perf Year-50.32%
Cash/sh2.44 P/C0.96 EPS next 5Y- ROE-754.31% 52W Range1.60 - 8.07 Perf YTD-34.11%
Dividend Est.- P/FCF- EPS past 5Y6.21% ROI- 52W High-71.01% Beta0.88
Dividend TTM- Quick Ratio0.43 Sales past 5Y105.16% Gross Margin-281.44% 52W Low46.25% ATR (14)0.35
Dividend Ex-Date- Current Ratio0.45 EPS Y/Y TTM38.67% Oper. Margin-2805.71% RSI (14)50.53 Volatility15.47% 16.05%
Employees107 Debt/Eq- Sales Y/Y TTM550.40% Profit Margin-2702.69% Recom1.67 Target Price5.67
Option/ShortYes / Yes LT Debt/Eq- EPS Q/Q40.60% Payout- Rel Volume1.92 Prev Close2.73
Sales Surprise0.10% EPS Surprise-21.49% Sales Q/Q836.61% EarningsMar 27 BMO Avg Volume74.95K Price2.34
SMA20-2.87% SMA502.67% SMA200-34.44% Trades Volume126,067 Change-14.29%
Date Action Analyst Rating Change Price Target Change
Mar-30-21Initiated Cantor Fitzgerald Overweight $8
Nov-05-20Initiated Ascendiant Capital Markets Buy $5
Jun-28-18Initiated Maxim Group Buy $5
Today 09:47AM
Mar-27-24 12:35PM
05:52AM
Mar-26-24 07:32PM
Mar-25-24 05:30PM
09:30AM Loading…
Mar-21-24 09:30AM
08:30AM
Mar-20-24 08:30AM
Mar-13-24 08:30AM
Mar-12-24 08:30AM
Feb-16-24 05:00PM
Feb-15-24 07:45AM
Feb-08-24 07:45AM
Dec-12-23 08:30AM
Dec-11-23 09:00AM
08:55AM Loading…
Dec-05-23 08:55AM
Dec-04-23 04:20PM
Dec-01-23 10:00AM
Nov-20-23 12:44PM
Nov-16-23 09:07AM
09:00AM
Nov-14-23 05:43PM
Nov-13-23 05:40PM
Nov-09-23 09:00AM
Nov-02-23 09:18AM
Nov-01-23 09:10AM
Oct-31-23 09:00AM
08:55AM
Sep-21-23 08:30AM
Sep-07-23 09:20AM
09:00AM Loading…
Sep-06-23 09:00AM
Aug-30-23 09:55AM
Aug-24-23 09:00AM
Aug-22-23 05:30PM
Aug-17-23 03:39AM
Aug-15-23 08:17PM
Aug-14-23 06:48PM
Jul-31-23 06:19PM
06:00PM
Jul-26-23 08:30AM
Jul-19-23 09:04AM
Jun-28-23 04:05PM
Jun-14-23 04:05PM
Jun-05-23 07:00AM
Jun-02-23 07:00AM
May-24-23 08:00AM
May-18-23 12:03PM
12:12AM
May-16-23 05:00PM
May-15-23 06:21PM
May-11-23 08:45AM
May-05-23 09:00AM
09:00AM
Apr-25-23 08:45AM
Apr-19-23 08:45AM
Apr-17-23 09:45PM
Mar-31-23 12:45PM
Mar-20-23 09:03PM
Mar-17-23 12:00PM
04:15AM
Mar-16-23 01:22AM
Mar-14-23 07:09PM
01:28PM
Mar-03-23 08:15AM
08:15AM
Feb-28-23 08:30AM
Feb-15-23 09:55AM
08:30AM
Jan-18-23 06:24AM
Jan-17-23 04:05PM
Jan-11-23 08:00AM
Dec-22-22 08:25AM
Dec-15-22 08:25AM
Dec-08-22 08:25AM
Dec-01-22 08:25AM
Nov-15-22 04:20PM
Nov-14-22 04:40PM
Nov-11-22 08:25AM
Nov-10-22 08:25AM
Nov-09-22 08:25AM
Nov-03-22 08:25AM
Nov-02-22 08:25AM
Aug-30-22 08:25AM
Aug-17-22 08:50AM
Aug-16-22 04:40PM
Aug-15-22 04:25PM
Aug-11-22 08:25AM
Aug-04-22 08:25AM
Aug-03-22 08:25AM
Jul-19-22 08:25AM
Jul-18-22 08:25AM
May-13-22 08:25AM
May-12-22 04:38PM
May-11-22 04:00PM
May-09-22 08:25AM
May-04-22 07:03AM
Apr-28-22 04:05PM
Apr-26-22 08:25AM
Apr-25-22 08:25AM
Apr-04-22 08:25AM
PAVmed, Inc. is a commercial-stage technology medical device company, which engages in the commercialization of medical technologies. It operates through the following divisions: Medical Devices, Diagnostics, Digital Health, and Emerging Innovations. Its products include cell collection devices, esophageal DNA tests, carpal tunnel release, implantable intraosseous vascular access devices, and antimicrobial resorbable ear tubes. The company was founded on June 26, 2014 and is headquartered in New York, NY.